ELAN (Elanco Animal Health) Change In Receivables : $0 Mil (TTM As of Dec. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Elanco Animal Health Change In Receivables?

Elanco Animal Health's change in receivables for the quarter that ended in Dec. 2024 was $0 Mil. It means Elanco Animal Health's Accounts Receivable stayed the same from Sep. 2024 to Dec. 2024 .

Elanco Animal Health's change in receivables for the fiscal year that ended in Dec. 2024 was $12 Mil. It means Elanco Animal Health's Accounts Receivable declined by $12 Mil from Dec. 2023 to Dec. 2024 .

Elanco Animal Health's Accounts Receivable for the quarter that ended in Dec. 2024 was $805 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Elanco Animal Health's Days Sales Outstanding for the three months ended in Dec. 2024 was 72.02.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Elanco Animal Health's liquidation value for the three months ended in Dec. 2024 was $-4,659 Mil.

Elanco Animal Health Change In Receivables Historical Data

The historical data trend for Elanco Animal Health's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Elanco Animal Health Change In Receivables Chart

Elanco Animal Health Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Receivables

Get a 7-Day Free Trial

24.00

-35.00

14.00

-40.00

12.00

Elanco Animal Health Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

Elanco Animal Health Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0 Mil.

Elanco Animal Health (NYSE:ELAN) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Elanco Animal Health's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	805	/	1020	*	91
=	72.02

2. In Ben Graham's calculation of liquidation value, Elanco Animal Health's accounts receivable are only considered to be worth 75% of book value:

Elanco Animal Health's liquidation value for the quarter that ended in Dec. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	468	-	6518	+	0.75 * 805	+	0.5 * 1574
=	-4,659

Elanco Animal Health Change In Receivables Related Terms

Thank you for viewing the detailed overview of Elanco Animal Health's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Elanco Animal Health Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Elanco Animal Health Inc (NYSE:ELAN) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

ELAN:Mexico 5EA:Germany

Address

2500 Innovation Way, Greenfield, IN, USA, 46140

Website

https://www.elanco.com

Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.

Executives

Lawrence Erik Kurzius	director	18 LOVETON CIRCLE, SPARKS MD 21152
R David Hoover	director	C/O EDGEWELL PERSONAL CARE COMPANY, 1350 TIMBERLAKE MANOR PARKWAY, CHESTERFIELD MO 63017
Michael J Harrington	director	LILLY CORPORATE CENTER, INDIANAPOLIS IN 46285
Jeffrey N Simmons	director, officer: Pres., Chief Executive Officer	2500 INNOVATION WAY, GREENFIELD IN 46140
William F Doyle	director
Grace Mcardle	officer: EVP, MANUFACTURING AND QUALITY	2500 INNOVATION WAY, GREENFIELD IN 46140
Timothy J Bettington	officer: See remarks	C/O ZOETIS INC., 10 SYLVAN WAY, PARSIPPANY NJ 07054
John P Bilbrey	director
Rajeev A. Modi	officer: See Remarks	2500 INNOVATION WAY, GREENFIELD IN 46140
Paul Herendeen	director	C/O BAUSCH HEALTH COMPANIES INC., 400 SOMERSET CORPORATE BLVD., BRIDGEWATER NJ 08807
Brabander Ellen De	officer: See Remarks	2500 INNOVATION WAY, GREENFIELD IN 46140
Marcela A. Kirberger	officer: Ex VP, Gen Counsel & Corp Sec	C/O ELANCO ANIMAL HEALTH INCORPORATED, 2500 INNOVATION WAY, GREENFIELD IN 46140
Art A Garcia	director	11690 N.W. 105TH STREET, MIAMI FL 33178
Uncas Gp Llc	director	250 WEST 55TH STREET, 34TH FLOOR, NEW YORK NY 10019
Sachem Head Gp Llc	director	250 WEST 55TH STREET, 34TH FLOOR, NEW YORK NY 10019